- Home
- PETS vs ICCM Comparison
PETS vs ICCM Comparison
Compare PETS & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PETS | ICCM |
|---|---|---|
| Founded | 1996 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.7M | 45.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PETS | ICCM |
|---|---|---|
| Price | $2.94 | $0.66 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $3.20 | $2.50 |
| AVG Volume (30 Days) | ★ 6.9M | 375.3K |
| Earning Date | 02-02-2026 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $226,972,000.00 | $2,975,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | $2.98 | $38.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.57 | $0.59 |
| 52 Week High | $6.08 | $1.66 |
Technical Indicators
Market Signals| Indicator | PETS | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 72.48 | 39.01 |
| Support Level | $1.69 | $0.67 |
| Resistance Level | $4.05 | $0.72 |
| Average True Range (ATR) | 0.24 | 0.03 |
| MACD | 0.15 | 0.00 |
| Stochastic Oscillator | 55.24 | 5.66 |
Price Performance
Historical ComparisonAbout PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.